Clinical Trial Update: Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a combination chemotherapy regimen with oblimersen in patients with advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Genasense (oblimersen)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED